Enhancing PAP Adherence Among Spanish-speaking Hispanic Adults With OSA

This study is looking for Spanish-speaking Hispanic adults with moderate to severe obstructive sleep apnea (OSA) to test a new way to help them use their positive airway pressure (PAP) machine more consistently. The study will use a tele-management intervention called Automated Management (AM), which sends text messages to your smartphone. These messages are designed to help you understand and use your PAP device better. The researchers want to see if this AM program is satisfying, acceptable, and appropriate for you to use over 6 months. This study aims to improve PAP use in a group that often faces challenges with this treatment. The study is currently unclear on its recruitment status.

Study design
This is a feasibility study involving 50 participants, where you would be randomly assigned to a group. It is a prospective, parallel group, unblinded trial.
What's involved
You would need to be available for the duration of the study, which is 6 months from the date you are randomized. You also need to own a smartphone with unlimited text messaging.
Compensation
Not stated in the trial record.
Follow-up
Your satisfaction, acceptability, and appropriateness of the intervention will be measured at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05618444

Enhancing PAP Adherence Among Spanish-speaking Hispanic Adults With OSA

Not Yet Recruiting
NAAges 18+InterventionalTreatment
Geisinger Clinic
~50 participants
Updated 2026-05-28 on ClinicalTrials.gov
What's tested:Automated Management (AM)

At a glance

Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Satisfaction
Measured over 6 months
+2 more outcomes measured
Obstructive Sleep Apnea
4 sites across 3 states
Pennsylvania2
California1
Kansas1
  • Alexa Watach, PhD, RN · PRINCIPAL_INVESTIGATOR · Unniversity of Pennsylvania

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Spanish-speaking and reading
Self-identified Hispanic
Adults ≥ 18 years-old
Males and females
Moderate-severe OSA defined as AHI ≥15 events/hour using a hypopnea criterion of a 4% oxygen desaturation (AHI4%)
Expected availability for the duration of the study (6 months from date of randomization)
Ownership of smartphone with unlimited text messaging capability
Referred to PAP treatment and able and willing to be treated with PAP

Exclusion

Other sleep apnea or nocturnal respiratory insufficiency or failure diagnosis other than OSA established by polysomnogram (PSG) or home sleep apnea test (HSAT)
Requirement of supplemental oxygen or other non-invasive ventilation modality
Women referred to PAP because of new-onset OSA with pregnancy as PAP treatment may be time-limited (enrolled women who become pregnant during the trial and are already on PAP treatment will not be excluded)
Anticipated or scheduled bariatric surgery and/or referred to sleep evaluation by bariatric surgery
  • Patient Satisfaction6 months

    Satisfaction with quality of care and the components of care (e.g., feedback, frequency, duration), relevance of the care to the individual and their needs, and overall satisfaction with care. Assessed with the Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 scores range from 8 to 32, with higher values indicating higher satisfaction.

  • Acceptability6 months

    Defined as the perception that a given treatment is agreeable, palatable, or satisfactory. Assessed with the Acceptability of Intervention Measure (AIM; 4 items, Likert, 1-5, where 1 = "completely disagree" and 5 = "completely agree"). Higher scores indicate higher acceptability.

  • Appropriateness6 months

    Defined as the perceived fit, relevance, or compatibility of a given treatment. Assessed with the Intervention Appropriateness Measure (IAM; 4 items, Likert, 1-5, where 1 = "completely disagree" and 5 = "completely agree"). Higher scores indicate higher appropriateness.